Bill Few Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
84,256
+1,957
| +2% | +$47.4K | 0.58% | 46 |
|
|
2025
Q1 | $2.09M | Buy |
82,299
+2,783
| +3% | +$70.5K | 0.75% | 39 |
|
|
2024
Q4 | $2.11M | Sell |
79,516
-7,247
| -8% | -$192K | 0.74% | 40 |
|
|
2024
Q3 | $2.51M | Buy |
86,763
+2,931
| +3% | +$84.8K | 0.89% | 33 |
|
|
2024
Q2 | $2.35M | Buy |
83,832
+1,224
| +1% | +$34.2K | 0.9% | 34 |
|
|
2024
Q1 | $2.29M | Buy |
82,608
+2,571
| +3% | +$71.3K | 0.93% | 30 |
|
|
2023
Q4 | $2.3M | Sell |
80,037
-783
| -1% | -$22.5K | 1.05% | 27 |
|
|
2023
Q3 | $2.68M | Buy |
80,820
+368
| +0.5% | +$12.2K | 1.4% | 23 |
|
|
2023
Q2 | $2.95M | Buy |
80,452
+2,225
| +3% | +$81.6K | 1.53% | 23 |
|
|
2023
Q1 | $3.19M | Buy |
78,227
+1,932
| +3% | +$78.8K | 1.77% | 19 |
|
|
2022
Q4 | $3.91M | Buy |
76,295
+2,211
| +3% | +$113K | 2.31% | 12 |
|
|
2022
Q3 | $3.24M | Buy |
74,084
+203
| +0.3% | +$8.88K | 2.19% | 15 |
|
|
2022
Q2 | $3.87M | Sell |
73,881
-1,486
| -2% | -$77.9K | 2.48% | 9 |
|
|
2022
Q1 | $3.9M | Buy |
75,367
+1,079
| +1% | +$55.9K | 2.12% | 14 |
|
|
2021
Q4 | $4.39M | Buy |
+74,288
| New | +$4.39M | 2.27% | 13 |
|